Parameters | ARV Triple Therapy |
| Value p | OR (IC 95%) |
| Yes (n = 34) | No (n = 14) |
|
|
Male Sex | 29.4% (10/34) | 57.1% (8/14) | 0.07 | 0.3 (0.9 - 1.1) |
High Blood Pressure | 17.6% (6/34) | 14.3% (2/14) | 0.77 | 1.3 (0.2 - 7.3) |
Diabetes | 11.8% (4/34) | 14.3% (2/14) | 0.81 | 0.8 (0.1 - 4.9) |
AIDS Stage | 52.9% (18/34) | 28.6% (4/14) | 0.12 | 2.8 (0.7 - 10.7) |
ARF Stage 3 | 64.7% (22/34) | 42.9% (6/14) | 0.16 | 2.4 (0.1 - 1.6) |
Anemia | 58.8% (20/34) | 42.9% (6/14) | 0.31 | 1.9 (0.5 - 6.7) |
Severe Anemia | 29.4% (10/34) | 14.3% (2/14) | 0.27 | 2.5 (0.5 - 13.3) |
CD4 count < 200 (/mm3) | 58.8% (20/34) | 28.6% (4/14) | 0.05 | 3.6 (0.9 - 13.7) |
Water Loss | 35.3% (12/34) | 14.3% (2/14) | 0.14 | 3.3 (0.6 - 17.1) |
Infections | 41.2% (14/34) | 28.6% (4/14) | 0.41 | 1.7 (0.5 - 6.7) |
Cancer | 5.9% (2/34) | 14.3% (2/14) | 0.33 | 0.3 (0.1 - 2.9) |
Other | 11.8% (4/34) | - | 0.18 | 1.4 (1.2 - 1.8) |